Neurocognitive Effects of Chemotherapy and Endocrine Therapies in the Treatment of Breast Cancer: Recent Perspectives

By Walker Caroline H.   Drew Barbara A.   Antoon James W.   Kalueff Alan V.   Beckman Barbara S.  

Cancer Investigation, Vol. 30, Iss. 2, 2012-02 ,pp. : 135-148

Informa Healthcare

Access to resources Recommend Favorite

Endocrine resistance in breast cancer: molecular pathways and rational development of targeted therapies

By Roop Ryan P   Ma Cynthia X  

Future Oncology, Vol. 8, Iss. 3, 2012-03 ,pp. : 273-292

Future Medicine

Access to resources Recommend Favorite

Emerging Endocrine Therapies in the Treatment of HR-Positive Metastatic Breast Cancer

By  

Current Cancer Therapy Reviews, Vol. 12, Iss. 1, 2016-10 ,pp. : 37-53

Bentham Science Publishers

Access to resources Recommend Favorite

New Endocrine Agents in the Treatment of Breast Cancer

By Mouridsen H.T.  

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 826-827

Elsevier

Access to resources Recommend Favorite

Development of new predictive markers for endocrine therapy and resistance in breast cancer

By Henriksen Katrine   Sonne-Hansen Katrine   Kirkegaard Tove   Frogne Thomas   Lykkesfeldt Anne  

Acta Oncologica, Vol. 47, Iss. 4, 2008-01 ,pp. : 795-801

Informa Healthcare

Access to resources Recommend Favorite